Home     Research Groups   Directory    Publications    
 
ANIMAL MODEL AND CANCER RESEARCH GROUP


icono_retroceder.gif Return


Aims

We are interested in study the mechanisms governing the molecular and genetic program in malignant melanoma development and progresion using the UV irradiated HGF transgenic malignant melanoma mouse model.Our final goal is the identifiction of new efective therpeutic targets.



Staff


Head of Animal model and Cancer Research Group: Juan Ángel Recio Conde
Lab Phone. 93 274 6026
jarecio@ir.vhebron.net


manimal_grup_2007.jpg

PhD Students
Rosaura Esteve Puig
Marta Fauquet
Pedro Antonio Andreu

Technical Personnel
Jessica Aranda






 

Research Areas



“Characterization of novel acting mechanisms of the Hepatocyte Growth Factor (HGF) in melanomagenesis: Bring into play the UV induced HGF transgenic animal model”.
Coordinator: Juan A. Recio Conde.
Applying proteomic technology and and biochemical and genetic approaches we willl try to get new insights about the mechanisms involved in melanoma development and progresion.

manimal_fig.jpg
“Preclinical study in melanoma development using specific PI3K and BRaf inhibitors.”.
Coordinator: Juan A. Recio Conde.
Investigations reveal that Ras and PI3K pathways appear to be important players in melanoma development. We are using specific inbitors against molecules to target this two pathways to test their therapeutic relevance in the mouse melanoma model.

Protein methylation as a modulator of cell signaling induced by growth factors and stress.”.
Coordinator: Juan A. Recio Conde.
Protein methylation is emerging as an important postranslational modification.We will sudy the cooperation between protein phosphorylation and protein mehylation in cell signaling mediated by growth factors and stress .


logo_vallhebron.jpg
logo_ics.jpg
logo_gene.jpg
logo_uab.jpg

logo_cibbim.jpg
logo_vhio.jpg
logo_bancsang.jpg
logo_farmaco.jpg
logo_cemcat.jpg
logo_idi.jpg


© Institut Recerca Hospital Universitari Vall d’Hebron
       institutrecerca@ir.vhebron.net  - Tel: +34 93 489 4337 - Fax: +34 93 489 4102
Login